Trial Profile
Phase I trial of multiple dose HSV 1716 in patients with recurrent glioblastoma
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Jan 2015
Price :
$35
*
At a glance
- Drugs HSV 1716 (Primary)
- Indications Glioblastoma
- Focus Adverse reactions; Therapeutic Use
- 29 Aug 2013 New trial record